uridine has been researched along with Cirrhosis, Liver in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Cheng, X; Li, D; Li, Y; Wang, S; Xiong, Y; Xu, Y; Zheng, WV; Zhou, T | 1 |
Asahina, Y; Biermer, M; Chayama, K; Hagiwara, Y; Hayashi, N; Hiramatsu, N; Huang, Y; Kurosaki, M; Nakano, T; Nozaki, A; Sakamoto, N; Shimizu, H; Takehara, T; Tanaka, Y; Vijgen, L; Yatsuhashi, H; Yoshida, H | 1 |
Almasio, PL; Barr, E; Bruno, S; Buti, M; Butterton, JR; Dutko, FJ; Fernsler, D; Gao, W; Grandhi, A; Hassanein, TI; Huang, HC; Jancoriene, L; Lawitz, E; Li, JJ; Liu, H; Muellhaupt, B; Nguyen, BT; Pearlman, B; Plank, RM; Robertson, MN; Ruane, PJ; Shepherd, A; Su, FH; Tannenbaum, B; Vierling, JM; Wahl, J; Wan, S; Yeh, WW; Yoshida, EM | 1 |
Brainard, DM; Curtis, C; Lasseter, K; Lawitz, E; Ling, KHJ; Marbury, T; Mathias, A; Mogalian, E; Moorehead, L; Murray, B; Osinusi, A; Perry, R | 1 |
Astruc, B; Beigelman, L; Berliba, E; Blatt, LM; Chanda, S; Fry, J; Kakuda, TN; Khorlin, N; McClure, MW; Patat, A; Streinu-Cercel, A; Tsertsvadze, T; Vijgen, L; Vuong, J; Westland, C; Zhang, Q | 1 |
Ackaert, O; Aghemo, A; Beumont, M; Biermer, M; Bourgeois, S; Buggisch, P; Buti, M; Corbett, C; Fevery, B; Greenbloom, S; Janczewska, E; Kalmeijer, R; Lampertico, P; Lim, SG; Moreno, C; Ouwerkerk-Mahadevan, S; Sinha, R; Tam, E; Vijgen, L; Willems, W; Zeuzem, S | 1 |
Amuro, Y; Fujii, J; Hada, T; Higashino, K; Moriwaki, Y; Nakano, T; Tamura, S; Yamamoto, T | 1 |
Amuro, Y; Fujioka, H; Hada, T; Higashino, K; Nakano, T; Nakao, N; Tamura, S | 1 |
Amuro, Y; Fujikura, M; Hada, T; Higashino, K; Nakaoka, H; Shimomura, S; Tamura, S; Yamamoto, T | 1 |
Prévost, JM; Thiry, L; Toussaint, C; Vereerstraeten, P | 1 |
5 trial(s) available for uridine and Cirrhosis, Liver
Article | Year |
---|---|
JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.
Topics: Adult; Aged; Alanine; Antiviral Agents; Benzimidazoles; Carbamates; Drug Combinations; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Indoles; Japan; Liver Cirrhosis; Male; Middle Aged; Phosphoramides; Simeprevir; Sustained Virologic Response; Treatment Outcome; Uridine | 2020 |
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2,
Topics: Adult; Amides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Administration Schedule; Female; Genotype; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Quinoxalines; Ribavirin; Sulfonamides; Sustained Virologic Response; Thiazoles; Uridine | 2017 |
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Carbamates; Drug Combinations; Drug Therapy, Combination; Female; Hepatic Insufficiency; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Sofosbuvir; Uridine; Young Adult | 2018 |
Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
Topics: Adult; Alanine; Antiviral Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Genotype; Half-Life; Hepacivirus; Hepatitis C; Humans; Liver Cirrhosis; Male; Middle Aged; Phosphoramides; Placebo Effect; RNA, Viral; Uridine | 2018 |
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1.
Topics: Adult; Aged; Alanine; Antiviral Agents; Benzimidazoles; Carbamates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Indoles; Internationality; Liver Cirrhosis; Male; Middle Aged; Patient Reported Outcome Measures; Patient Selection; Phosphoramides; Severity of Illness Index; Simeprevir; Sustained Virologic Response; Time Factors; Treatment Outcome; Uridine; Young Adult | 2019 |
5 other study(ies) available for uridine and Cirrhosis, Liver
Article | Year |
---|---|
Uridine alleviates carbon tetrachloride-induced liver fibrosis by regulating the activity of liver-related cells.
Topics: Animals; Carbon Tetrachloride; Hepatic Stellate Cells; Hepatocytes; Liver; Liver Cirrhosis; Uridine | 2022 |
Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
Topics: Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pseudouridine; Uridine | 1986 |
Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Monitoring, Physiologic; Necrosis; Pseudouridine; Uridine | 1988 |
Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Hepatitis; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pseudouridine; Uridine | 1988 |
[Viral complications of renal transplantation].
Topics: Azathioprine; Cytarabine; Cytomegalovirus; DNA Viruses; DNA, Viral; Hepatitis A; Hepatitis B virus; Herpesviridae Infections; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Cirrhosis; Transplantation Immunology; Transplantation, Homologous; Uridine; Virus Diseases | 1971 |